Sushrutha Chempharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 27-10-2024
- Paid Up Capital ₹ 0.10 M
as on 27-10-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 Cr
as on 27-10-2024
- Revenue %
(FY 2022)
- Profit -5365.75%
(FY 2022)
- Net Worth -607.31%
(FY 2022)
- Total Assets 402.88%
(FY 2022)
About Sushrutha Chempharma
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.00 Cr.
Rajani Nuthanapati, Ravi Sujatha, and Payyavula Jayachandrika serve as directors at the Company.
- CIN/LLPIN
U24231TG2020PTC142968
- Company No.
142968
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Aug 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- LocationHyderabad, Telangana
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sushrutha Chempharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajani Nuthanapati  | Managing Director | 19-Aug-2020 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravi Sujatha | Director | 19-Aug-2020 | Current |
| Payyavula Jayachandrika | Director | 22-Dec-2021 | Current |
Financial Performance of Sushrutha Chempharma.
Sushrutha Chempharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 5365.75% decrease in profit. The company's net worth observed a substantial decline by a decrease of 607.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sushrutha Chempharma?
Unlock access to Sushrutha Chempharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 25 Nov 2022 | ₹8.00 Cr | Open |
How Many Employees Work at Sushrutha Chempharma?
Unlock and access historical data on people associated with Sushrutha Chempharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sushrutha Chempharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sushrutha Chempharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
